Abbott Laboratories (ABT) Net Income Growth (5y) (2014 - 2026)
Abbott Laboratories (ABT) Net Income Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn |
| 10 | Steris | 21.43 Bn | 20.99 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.69% |
| Dec 31, 2025 | 238.44% |
| Mar 31, 2025 | 131.33% |
| Dec 31, 2024 | 54.48% |
| Sep 30, 2024 | 11.39% |
| Jun 30, 2024 | 5.29% |
| Mar 31, 2024 | 12.76% |
| Dec 31, 2023 | 337.13% |
| Sep 30, 2023 | 164.94% |
| Jun 30, 2023 | 146.86% |
| Mar 31, 2023 | 171.10% |
| Dec 31, 2022 | 95.69% |
| Sep 30, 2022 | 102.64% |
| Jun 30, 2022 | 174.28% |
| Mar 31, 2022 | 136.61% |
| Dec 31, 2021 | 54.86% |
| Sep 30, 2021 | 137.14% |
| Jun 30, 2021 | 136.71% |
| Mar 31, 2021 | 156.98% |
| Dec 31, 2020 | -10.59% |